Results For "0"

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform Blog Post

PRINCETON, NJ – 2024年4月16日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying platform that integrates…

Certara Announces New Corporate Headquarters Blog Post

New, spacious location in Radnor, Pennsylvania will support the needs of company’s growing workforce and business, strengthen presence in the state RADNOR, PA – 2024年4月15日 – Certara, Inc….

バイオシミラーとは何ですか？また、どのように開発されるのですか？ Blog Post

バイオシミラーについて学びましょう。バイオ医薬品を使用する患者にとっての利点や、製薬会社が承認されたバイオシミラーとの生物学的同等性をどのように証明するかについてご紹介します。

Enhancing Regulatory Writing: The Power of Style Guides Blog Post

TranscriptMany pharmaceutical industry professionals once considered standardizing regulatory writing style conventions unnecessary and time-consuming. However, the industry now recognizes its benefits for maximizing efficiency during regulatory submission development. The benefits of using…

Molecular Glue Drug Development Summit 2024 Recap Blog Post

Transcript: Hello, and welcome to Certara Talks. I’m Doctor Suzanne Minton, and I’m a director of content strategy at Certara . Today, I’m talking to my colleague, doctor Joshua Apgar….

CRF Design Checklist Blog Post

Our free, downloadable CRF design checklist can help you design quality case report forms that meet all your study requirements.

Supporting the Approval of a Treatment for a Neglected Tropical Disease Blog Post

In this video, Dr. Mark Sullivan, Managing Director of Medicines Development for Global Health, explains how Certara’s model-informed drug development expertise was used to support developing moxidectin as a treatment…

Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference Blog Post

PRINCETON, N.J.— 2024年4月9日– Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2024 after the…

An Endogenous Biomarker for Predicting OATP1B DDIs Blog Post

このブログでは、OATP1Bトランスポーターによる薬物間相互作用（DDI）を評価するための内因性バイオマーカーであるCP-1の役割と、その臨床的影響についてレビューします。

臨床メタデータリポジトリに期待すべき役割とは？ Blog Post

Gilbert Hunter 2024年4月4日 As the clinical research industry moves towards more efficient and automated processes, clinical metadata repositories are becoming a must. You’ve probably heard of them; sometimes they...